filmov
tv
Resistant Chronic Myeloid Leukemia

Показать описание
Resistant Chronic Myeloid Leukemia
Treatment Selection for Resistant or Intolerant Chronic Myeloid Leukemia
Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial
Targeting TKI-resistant CML with LY3009120 and asciminib
Alternative Mechanism for Treatment of Resistant CML
Addressing the issue of resistance to TKIs in CML
Understanding the cause of TKI resistance to improve management strategies in CML
Emerging therapeutic approaches for TKI-resistant CML
Resistance to Targeted-TKI Treatment in Patients With CML
OPTIC: ponatinib in resistant chronic-phase CML
Chronic Myeloid Leukemia (CML) - Treatment - Tyrosine Kinase (TK) Inhibitors
Experience with Omacetaxine for TKI-Resistant TKI CML
Treatment Options for Chronic Myeloid Leukemia (CML) -
The role of CML stem cells in relapse after TKI discontinuation & resistance to treatment
Mechanisms of resistance to the TKI asciminib in CML
Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape
Asciminib: overcoming TKI resistance and reducing toxicity in CML
Novel treatment strategies for patients with CML who are intolerant or resistant to available TKIs
Managing drug resistance in CP-CML with ponatinib and asciminib
Chronic Myeloid Leukemia: Understanding Loss of Response
Unmet needs in CML: dealing with resistance and progression, pregnancy, QoL & access to treatmen...
Unmet Needs Researchers are Investigating in Chronic Myeloid Leukemia
Ibrutinib resistance-mechanisms and options in CLL
Downregulation of MS4A3 promotes TKI resistance in CML
Комментарии